Clinical Trial Update: Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on remimazolam for postoperative nausea and vomiting in high-risk patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Peking University First Hospital | Conditions: Postoperative Nausea and Vomiting, Benzodiazepine | Phase 4 | Status: COMPLETED